Spatial working memory impairments induced by cigarette smoking abstinence are correlated with plasma nicotine levels in schizophrenia

Schizophrenia Research

Volumn 128, Issue 1-3, 2011, Pages 171-172

  Wing, Victoria C ^a   Sacco, Kristi A ^b   George, Tony P ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; MECAMYLAMINE; NEUROTRANSMITTER; NICOTINE; PLACEBO;

BLOOD LEVEL; BRAIN FUNCTION; CIGARETTE SMOKING; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; LETTER; MEMORY DISORDER; NICOTINE BLOOD LEVEL; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SMOKING CESSATION; SPATIAL MEMORY; WITHDRAWAL SYNDROME; WORKING MEMORY;

HUMANS; MECAMYLAMINE; MEMORY DISORDERS; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; NICOTINE; NICOTINIC ANTAGONISTS; SCHIZOPHRENIA; SMOKING; SMOKING CESSATION;

EID: 79955479366     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.10.011     Document Type: Letter

References (9)

1. Breese C.R., Lee M.J., Adams C.E., Sullivan B., Logel J., Gillen K.M., Marks M.J., Collins A.C., Leonard S. Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology 2000, 23:351-364.
2. Dolan S.L., Sacco K.A., Termine A., Seyal A.A., Dudas M.M., Vessicchio J.C., Wexler B.E., George T.P. Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia. Schizophrenia Research 2004, 70:263-275.
3. George T.P. Neurobiological links between nicotine addiction and schizophrenia. Journal of Dual Diagnosis 2007, 3:27-42.
4. George T.P., Vessicchio J.C., Termine A., Sahady D.M., Head C.A., Pepper W.T., Kosten T.R., Wexler B.E. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology 2002, 26:75-85.
5. Moss T.G., Sacco K.A., Allen T.M., Weinberger A.H., Vessicchio J.C., George T.P. Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia. Drug and Alcohol Dependence 2009, 104:94-99.
6. Olincy A., Young D.A., Freedman R. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biological Psychiatry 1997, 42:1-5.
7. Picciotto M.R., Addy N.A., Mineur Y.S., Brunzell D.H. It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Progress in Neurobiology 2008, 84:329-342.
8. Sacco K.A., Termine A., Seyal A., Dudas M.M., Vessicchio J.C., Krishnan-Sarin S., Jatlow P.I., Wexler B.E., George T.P. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Archives of General Psychiatry 2005, 62:649-659.
9. Sacco K.A., Creeden C., Reutenauer E.L., Vessicchio J.C., Weinberger A.H., George T.P. Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia. Schizophrenia Research 2009, 107:332-333.